Bloomberg School Researchers Develop Universal Risk Predictor for Cardiovascular Disease

Universal risk predictor for cardiovascular disease, suitable for use in both primary and secondary prevention, would streamline risk assessmentPublishedJanuary 29, 2024EPIDEMIOLOGYResearchers from th

Updated on: February 18,2024

Bloomberg School Researchers Develop Universal Risk Predictor for Cardiovascular Disease

Universal risk predictor for cardiovascular disease, suitable for use in both primary and secondary prevention, would streamline risk assessmentPublishedJanuary 29, 2024EPIDEMIOLOGYResearchers from th

Updated on:February 18,2024

Treating Alzheimer's, Parkinson's, type 2 diabetes by eliminating protein aggregation in brain, pancreas

by Steve Martin,Purdue UniversityCredit: Wikimedia CommonsPurdue University researchers have taken the first steps to treat Alzheimer's disease, Parkinson's disease and Type 2 diabetes b

Updated on: May 06,2024

Treating Alzheimer's, Parkinson's, type 2 diabetes by eliminating protein aggregation in brain, pancreas

by Steve Martin,Purdue UniversityCredit: Wikimedia CommonsPurdue University researchers have taken the first steps to treat Alzheimer's disease, Parkinson's disease and Type 2 diabetes b

Updated on:May 06,2024

Experts reach consensus on gene therapy carcinogenicity risks

byMary Ann Liebert, IncCredit: CC0 Public DomainAnarticlein the journalHuman Gene Therapydescribes the consensus reached by invited experts who participated in a meeting

Updated on: September 03,2024

Experts reach consensus on gene therapy carcinogenicity risks

byMary Ann Liebert, IncCredit: CC0 Public DomainAnarticlein the journalHuman Gene Therapydescribes the consensus reached by invited experts who participated in a meeting

Updated on:September 03,2024

Combination cancer therapies can shrink tumors and improve outcome in advanced non-small lung cancer: Clinical trial

byYale UniversityCredit: Pixabay/CC0 Public DomainWhile pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer (NSCLC), only some patients respond to this

Updated on: January 08,2024

Combination cancer therapies can shrink tumors and improve outcome in advanced non-small lung cancer: Clinical trial

byYale UniversityCredit: Pixabay/CC0 Public DomainWhile pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer (NSCLC), only some patients respond to this

Updated on:January 08,2024

Black women with breast cancer may have worse outcomes than peers despite similar genetic recurrence scores

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainNon-Hispanic Black women with hormone receptor (HR)-positive/HER2-negative, lymph node-positive breast cancer had wors

Updated on: December 24,2023

Black women with breast cancer may have worse outcomes than peers despite similar genetic recurrence scores

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainNon-Hispanic Black women with hormone receptor (HR)-positive/HER2-negative, lymph node-positive breast cancer had wors

Updated on:December 24,2023

Brain tumor organoids may be key to time-sensitive treatments for glioblastomas

byPerelman School of Medicine at the University of PennsylvaniaGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Lab-grown brain organoids developed from a patient's own glioblas

Updated on: December 22,2023

Brain tumor organoids may be key to time-sensitive treatments for glioblastomas

byPerelman School of Medicine at the University of PennsylvaniaGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Lab-grown brain organoids developed from a patient's own glioblas

Updated on:December 22,2023

Researchers develop new open-source method to improve decoding of single-cell data

by Ian Demsky,Memorial Sloan Kettering Cancer CenterSpectra uses gene sets and cell types to guide gene program discovery from scRNA-seq data.a, As input, Spectra receives a gene expressio

Updated on: June 11,2024

Researchers develop new open-source method to improve decoding of single-cell data

by Ian Demsky,Memorial Sloan Kettering Cancer CenterSpectra uses gene sets and cell types to guide gene program discovery from scRNA-seq data.a, As input, Spectra receives a gene expressio

Updated on:June 11,2024

Common hair loss and prostate drug may also cut heart disease risk

by Lauren Quinn,University of Illinois at Urbana-ChampaignFinasteride decreases plaque size and macrophage content in Ldlr-/-mice. Four-week-old male Ldlr-/-mice were fed Western die

Updated on: March 25,2024

Common hair loss and prostate drug may also cut heart disease risk

by Lauren Quinn,University of Illinois at Urbana-ChampaignFinasteride decreases plaque size and macrophage content in Ldlr-/-mice. Four-week-old male Ldlr-/-mice were fed Western die

Updated on:March 25,2024

Photodynamic therapy offers promise for cancer treatment

by Marcia Kaye,University of Toronto MississaugaHuman colorectal cancer cells. Credit: National Cancer Institute/UnsplashWhile chemotherapy drugs can be lifesaving, they don't work for all p

Updated on: December 23,2023

Photodynamic therapy offers promise for cancer treatment

by Marcia Kaye,University of Toronto MississaugaHuman colorectal cancer cells. Credit: National Cancer Institute/UnsplashWhile chemotherapy drugs can be lifesaving, they don't work for all p

Updated on:December 23,2023

Cancer cases will keep rising worldwide: Report

by Dennis ThompsonCancer cases will continue to climb for the next two decades, spurred on by an aging worldwide population, a new report shows.An estimated 20 million new cancer cases were diagnosed

Updated on: April 06,2024

Cancer cases will keep rising worldwide: Report

by Dennis ThompsonCancer cases will continue to climb for the next two decades, spurred on by an aging worldwide population, a new report shows.An estimated 20 million new cancer cases were diagnosed

Updated on:April 06,2024

Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

byUniversity of Miami Leonard M. Miller School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers conducting a Phase 2 clinical trial at Sylvester Comp

Updated on: January 26,2024

Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

byUniversity of Miami Leonard M. Miller School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers conducting a Phase 2 clinical trial at Sylvester Comp

Updated on:January 26,2024

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on: July 10,2024

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on:July 10,2024